| UniProt ID | PLAP_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y263 | |
| Protein Name | Phospholipase A-2-activating protein | |
| Gene Name | PLAA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 795 | |
| Subcellular Localization | Nucleus . Cytoplasm . Cell junction, synapse . Recruited to damaged lysosomes decorated with K48-linked ubiquitin chains. | |
| Protein Description | Plays a role in protein ubiquitination, sorting and degradation through its association with VCP. [PubMed: 27753622 Involved in ubiquitin-mediated membrane proteins trafficking to late endosomes in an ESCRT-dependent manner, and hence plays a role in synaptic vesicle recycling (By similarity May play a role in macroautophagy, regulating for instance the clearance of damaged lysosomes] | |
| Protein Sequence | MTSGATRYRLSCSLRGHELDVRGLVCCAYPPGAFVSVSRDRTTRLWAPDSPNRSFTEMHCMSGHSNFVSCVCIIPSSDIYPHGLIATGGNDHNICIFSLDSPMPLYILKGHKNTVCSLSSGKFGTLLSGSWDTTAKVWLNDKCMMTLQGHTAAVWAVKILPEQGLMLTGSADKTVKLWKAGRCERTFSGHEDCVRGLAILSETEFLSCANDASIRRWQITGECLEVYYGHTNYIYSISVFPNCRDFVTTAEDRSLRIWKHGECAQTIRLPAQSIWCCCVLDNGDIVVGASDGIIRVFTESEDRTASAEEIKAFEKELSHATIDSKTGDLGDINAEQLPGREHLNEPGTREGQTRLIRDGEKVEAYQWSVSEGRWIKIGDVVGSSGANQQTSGKVLYEGKEFDYVFSIDVNEGGPSYKLPYNTSDDPWLTAYNFLQKNDLNPMFLDQVAKFIIDNTKGQMLGLGNPSFSDPFTGGGRYVPGSSGSSNTLPTADPFTGAGRYVPGSASMGTTMAGVDPFTGNSAYRSAASKTMNIYFPKKEAVTFDQANPTQILGKLKELNGTAPEEKKLTEDDLILLEKILSLICNSSSEKPTVQQLQILWKAINCPEDIVFPALDILRLSIKHPSVNENFCNEKEGAQFSSHLINLLNPKGKPANQLLALRTFCNCFVGQAGQKLMMSQRESLMSHAIELKSGSNKNIHIALATLALNYSVCFHKDHNIEGKAQCLSLISTILEVVQDLEATFRLLVALGTLISDDSNAVQLAKSLGVDSQIKKYSSVSEPAKVSECCRFILNLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTSGATRYR ------CCCCCCEEE | 35.55 | 20860994 | |
| 3 | Phosphorylation | -----MTSGATRYRL -----CCCCCCEEEE | 25.73 | 20860994 | |
| 6 | Phosphorylation | --MTSGATRYRLSCS --CCCCCCEEEEEEE | 31.58 | - | |
| 8 | Phosphorylation | MTSGATRYRLSCSLR CCCCCCEEEEEEECC | 16.14 | 30631047 | |
| 13 | Phosphorylation | TRYRLSCSLRGHELD CEEEEEEECCCCEEE | 20.09 | 30631047 | |
| 50 | Phosphorylation | TRLWAPDSPNRSFTE CCEECCCCCCCCCCE | 24.02 | 30266825 | |
| 112 | Ubiquitination | LYILKGHKNTVCSLS EEEECCCCCEEEECC | 64.08 | 29967540 | |
| 122 | Ubiquitination | VCSLSSGKFGTLLSG EEECCCCCCCEECCC | 42.44 | 32015554 | |
| 125 | Phosphorylation | LSSGKFGTLLSGSWD CCCCCCCEECCCCCC | 27.88 | 27067055 | |
| 173 | Ubiquitination | MLTGSADKTVKLWKA EEECCCCCCEEEEEC | 55.74 | 29967540 | |
| 176 | Ubiquitination | GSADKTVKLWKAGRC CCCCCCEEEEECCCC | 54.59 | 27667366 | |
| 179 | Ubiquitination | DKTVKLWKAGRCERT CCCEEEEECCCCCCC | 51.94 | 27667366 | |
| 186 | Phosphorylation | KAGRCERTFSGHEDC ECCCCCCCCCCCHHH | 10.40 | 23312004 | |
| 188 | Phosphorylation | GRCERTFSGHEDCVR CCCCCCCCCCHHHHH | 38.33 | 23312004 | |
| 259 | Ubiquitination | DRSLRIWKHGECAQT HCCEEEEECCHHHCC | 39.08 | 21906983 | |
| 303 | Methylation | VFTESEDRTASAEEI EEECCCCCCCCHHHH | 28.30 | 115487723 | |
| 311 | Ubiquitination | TASAEEIKAFEKELS CCCHHHHHHHHHHHH | 50.75 | 23000965 | |
| 311 | Acetylation | TASAEEIKAFEKELS CCCHHHHHHHHHHHH | 50.75 | 25953088 | |
| 315 | Ubiquitination | EEIKAFEKELSHATI HHHHHHHHHHHCCEE | 58.46 | 23000965 | |
| 315 | Malonylation | EEIKAFEKELSHATI HHHHHHHHHHHCCEE | 58.46 | 26320211 | |
| 315 | Acetylation | EEIKAFEKELSHATI HHHHHHHHHHHCCEE | 58.46 | 23236377 | |
| 318 | Phosphorylation | KAFEKELSHATIDSK HHHHHHHHCCEECCC | 16.50 | 27251275 | |
| 325 | Ubiquitination | SHATIDSKTGDLGDI HCCEECCCCCCCCCC | 53.42 | 21906983 | |
| 326 | Phosphorylation | HATIDSKTGDLGDIN CCEECCCCCCCCCCC | 39.62 | 28857561 | |
| 361 | Ubiquitination | RLIRDGEKVEAYQWS EEEECCCEEEEEEEE | 51.40 | 29967540 | |
| 376 | Ubiquitination | VSEGRWIKIGDVVGS ECCCCEEEEEEEECC | 33.41 | 23000965 | |
| 383 | Phosphorylation | KIGDVVGSSGANQQT EEEEEECCCCCCCCC | 17.62 | 23403867 | |
| 384 | Phosphorylation | IGDVVGSSGANQQTS EEEEECCCCCCCCCC | 35.68 | 23403867 | |
| 390 | Phosphorylation | SSGANQQTSGKVLYE CCCCCCCCCCEEEEC | 29.68 | 23403867 | |
| 391 | Phosphorylation | SGANQQTSGKVLYEG CCCCCCCCCEEEECC | 32.07 | 23403867 | |
| 393 | Ubiquitination | ANQQTSGKVLYEGKE CCCCCCCEEEECCCE | 28.91 | 23000965 | |
| 396 | Phosphorylation | QTSGKVLYEGKEFDY CCCCEEEECCCEEEE | 26.14 | 28270605 | |
| 399 | Ubiquitination | GKVLYEGKEFDYVFS CEEEECCCEEEEEEE | 43.18 | 23000965 | |
| 403 | Phosphorylation | YEGKEFDYVFSIDVN ECCCEEEEEEEEECC | 14.55 | 28270605 | |
| 406 | Phosphorylation | KEFDYVFSIDVNEGG CEEEEEEEEECCCCC | 14.08 | 28270605 | |
| 415 | Phosphorylation | DVNEGGPSYKLPYNT ECCCCCCCCCCCCCC | 37.87 | 25627689 | |
| 436 | Ubiquitination | TAYNFLQKNDLNPMF HHHHHHHHCCCCHHH | 55.35 | 23503661 | |
| 449 | Ubiquitination | MFLDQVAKFIIDNTK HHHHHHHHHHCCCCC | 37.93 | 33845483 | |
| 456 | Acetylation | KFIIDNTKGQMLGLG HHHCCCCCCCEECCC | 54.09 | 7407777 | |
| 456 | Ubiquitination | KFIIDNTKGQMLGLG HHHCCCCCCCEECCC | 54.09 | 23000965 | |
| 459 | Sulfoxidation | IDNTKGQMLGLGNPS CCCCCCCEECCCCCC | 4.34 | 21406390 | |
| 466 | Phosphorylation | MLGLGNPSFSDPFTG EECCCCCCCCCCCCC | 41.19 | 28857561 | |
| 468 | Phosphorylation | GLGNPSFSDPFTGGG CCCCCCCCCCCCCCC | 49.03 | 28555341 | |
| 477 | Phosphorylation | PFTGGGRYVPGSSGS CCCCCCCCCCCCCCC | 17.80 | 30242111 | |
| 481 | Phosphorylation | GGRYVPGSSGSSNTL CCCCCCCCCCCCCCC | 26.00 | 30242111 | |
| 482 | Phosphorylation | GRYVPGSSGSSNTLP CCCCCCCCCCCCCCC | 48.92 | 26657352 | |
| 484 | Phosphorylation | YVPGSSGSSNTLPTA CCCCCCCCCCCCCCC | 23.51 | 26657352 | |
| 485 | Phosphorylation | VPGSSGSSNTLPTAD CCCCCCCCCCCCCCC | 37.04 | 30242111 | |
| 487 | Phosphorylation | GSSGSSNTLPTADPF CCCCCCCCCCCCCCC | 35.74 | 30242111 | |
| 490 | Phosphorylation | GSSNTLPTADPFTGA CCCCCCCCCCCCCCC | 46.97 | 27251275 | |
| 495 | Phosphorylation | LPTADPFTGAGRYVP CCCCCCCCCCCCCCC | 31.35 | 30242111 | |
| 500 | Phosphorylation | PFTGAGRYVPGSASM CCCCCCCCCCCCCCC | 15.30 | 21945579 | |
| 504 | Phosphorylation | AGRYVPGSASMGTTM CCCCCCCCCCCCCCC | 15.88 | 21945579 | |
| 506 | Phosphorylation | RYVPGSASMGTTMAG CCCCCCCCCCCCCCC | 21.31 | 21945579 | |
| 506 | Ubiquitination | RYVPGSASMGTTMAG CCCCCCCCCCCCCCC | 21.31 | 23000965 | |
| 509 | Phosphorylation | PGSASMGTTMAGVDP CCCCCCCCCCCCCCC | 12.54 | 21945579 | |
| 510 | Phosphorylation | GSASMGTTMAGVDPF CCCCCCCCCCCCCCC | 10.17 | 21945579 | |
| 514 | Ubiquitination | MGTTMAGVDPFTGNS CCCCCCCCCCCCCCH | 6.49 | 29967540 | |
| 515 | Ubiquitination | GTTMAGVDPFTGNSA CCCCCCCCCCCCCHH | 31.51 | 29967540 | |
| 518 | Phosphorylation | MAGVDPFTGNSAYRS CCCCCCCCCCHHHHH | 40.62 | 21945579 | |
| 521 | Phosphorylation | VDPFTGNSAYRSAAS CCCCCCCHHHHHHHC | 28.20 | 21945579 | |
| 523 | Phosphorylation | PFTGNSAYRSAASKT CCCCCHHHHHHHCCE | 12.62 | 21945579 | |
| 529 | Acetylation | AYRSAASKTMNIYFP HHHHHHCCEEEEEEC | 47.25 | 19608861 | |
| 529 | Ubiquitination | AYRSAASKTMNIYFP HHHHHHCCEEEEEEC | 47.25 | 23000965 | |
| 531 | Ubiquitination | RSAASKTMNIYFPKK HHHHCCEEEEEECCC | 3.10 | 23503661 | |
| 533 | Ubiquitination | AASKTMNIYFPKKEA HHCCEEEEEECCCCC | 2.32 | 27667366 | |
| 537 | Ubiquitination | TMNIYFPKKEAVTFD EEEEEECCCCCEECC | 54.04 | 29967540 | |
| 538 | Ubiquitination | MNIYFPKKEAVTFDQ EEEEECCCCCEECCC | 51.66 | 21906983 | |
| 543 | Ubiquitination | PKKEAVTFDQANPTQ CCCCCEECCCCCHHH | 5.42 | 27667366 | |
| 544 | Ubiquitination | KKEAVTFDQANPTQI CCCCEECCCCCHHHH | 37.00 | 29967540 | |
| 554 | Ubiquitination | NPTQILGKLKELNGT CHHHHHHHHHHHCCC | 53.60 | 23503661 | |
| 554 | Acetylation | NPTQILGKLKELNGT CHHHHHHHHHHHCCC | 53.60 | 23954790 | |
| 554 | Malonylation | NPTQILGKLKELNGT CHHHHHHHHHHHCCC | 53.60 | 26320211 | |
| 556 | Ubiquitination | TQILGKLKELNGTAP HHHHHHHHHHCCCCC | 64.74 | 27667366 | |
| 566 | Ubiquitination | NGTAPEEKKLTEDDL CCCCCHHHCCCHHHH | 51.96 | 27667366 | |
| 567 | Ubiquitination | GTAPEEKKLTEDDLI CCCCHHHCCCHHHHH | 65.01 | 22053931 | |
| 590 | Ubiquitination | ICNSSSEKPTVQQLQ HHCCCCCCCCHHHHH | 48.19 | 21906983 | |
| 599 | Ubiquitination | TVQQLQILWKAINCP CHHHHHHHHHHCCCC | 2.18 | 23000965 | |
| 605 | Glutathionylation | ILWKAINCPEDIVFP HHHHHCCCCHHHHHH | 2.97 | 22555962 | |
| 611 | Ubiquitination | NCPEDIVFPALDILR CCCHHHHHHHHHHHH | 2.75 | 32015554 | |
| 622 | Ubiquitination | DILRLSIKHPSVNEN HHHHHHCCCCCCCCC | 46.19 | 23000965 | |
| 627 | Ubiquitination | SIKHPSVNENFCNEK HCCCCCCCCCCCCHH | 42.71 | 29967540 | |
| 629 | Ubiquitination | KHPSVNENFCNEKEG CCCCCCCCCCCHHHH | 41.38 | 22505724 | |
| 634 | Ubiquitination | NENFCNEKEGAQFSS CCCCCCHHHHCHHHH | 47.67 | 32015554 | |
| 650 | Ubiquitination | LINLLNPKGKPANQL HHHHHCCCCCCHHHH | 77.74 | 29967540 | |
| 652 | Ubiquitination | NLLNPKGKPANQLLA HHHCCCCCCHHHHHH | 47.27 | 22505724 | |
| 652 | Malonylation | NLLNPKGKPANQLLA HHHCCCCCCHHHHHH | 47.27 | 26320211 | |
| 668 | Ubiquitination | RTFCNCFVGQAGQKL HHHHHHHHHHHHHHH | 6.39 | 29967540 | |
| 678 | Phosphorylation | AGQKLMMSQRESLMS HHHHHHHHHHHHHHH | 16.48 | - | |
| 682 | Phosphorylation | LMMSQRESLMSHAIE HHHHHHHHHHHHHHH | 31.40 | 29083192 | |
| 691 | Acetylation | MSHAIELKSGSNKNI HHHHHHHCCCCCCCH | 39.72 | 20167786 | |
| 691 | Ubiquitination | MSHAIELKSGSNKNI HHHHHHHCCCCCCCH | 39.72 | 2190698 | |
| 750 | Ubiquitination | FRLLVALGTLISDDS HHHHHHHHHHHCCCC | 14.56 | 27667366 | |
| 751 | Ubiquitination | RLLVALGTLISDDSN HHHHHHHHHHCCCCC | 23.05 | 29967540 | |
| 760 | Ubiquitination | ISDDSNAVQLAKSLG HCCCCCHHHHHHHCC | 5.84 | 29967540 | |
| 773 | Ubiquitination | LGVDSQIKKYSSVSE CCCCHHHHHCCCCCC | 37.71 | 27667366 | |
| 774 | Ubiquitination | GVDSQIKKYSSVSEP CCCHHHHHCCCCCCC | 52.58 | 29967540 | |
| 776 | Phosphorylation | DSQIKKYSSVSEPAK CHHHHHCCCCCCCHH | 32.89 | 20860994 | |
| 783 | Ubiquitination | SSVSEPAKVSECCRF CCCCCCHHHHHHHHH | 57.94 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLAP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLAP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLAP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TERA_HUMAN | VCP | physical | 19887378 | |
| UBC_HUMAN | UBC | physical | 19423704 | |
| PDIA3_HUMAN | PDIA3 | physical | 22484374 | |
| CAV1_HUMAN | CAV1 | physical | 22484374 | |
| NSF1C_HUMAN | NSFL1C | physical | 22863883 | |
| PARP6_HUMAN | PARP6 | physical | 22863883 | |
| PCNA_HUMAN | PCNA | physical | 22863883 | |
| TBB2A_HUMAN | TUBB2A | physical | 22863883 | |
| EFTU_HUMAN | TUFM | physical | 22863883 | |
| TWF2_HUMAN | TWF2 | physical | 22863883 | |
| UBXN1_HUMAN | UBXN1 | physical | 22863883 | |
| UBXN1_HUMAN | UBXN1 | physical | 25416956 | |
| BASP1_HUMAN | BASP1 | physical | 26344197 | |
| XPO2_HUMAN | CSE1L | physical | 26344197 | |
| FPPS_HUMAN | FDPS | physical | 26344197 | |
| PAK2_HUMAN | PAK2 | physical | 26344197 | |
| SF01_HUMAN | SF1 | physical | 26344197 | |
| XPP1_HUMAN | XPNPEP1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-529, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND MASSSPECTROMETRY. | |